CHERRY HILL, N.J., March 18 /PRNewswire-FirstCall/ -- Nuvilex, Inc. (OTC Bulletin Board: NVLX), formerly eFoodSafety.com, Inc. (OTC Bulletin Board: EFSF), announced today that Infinitink(TM), , the world's first permanent tattoo ink designed to be safe and easier to remove, was the subject of an alt.news 26.46 television segment shown on February 22, 2009 on PBS member station WSIU. The program covers the research and development of the ink as well as its use in creating permanent tattoos and its ability to be removed with far fewer laser treatments. Infinitink is the product of Nuvilex' new wholly-owned subsidiary, Freedom2.
The television segment can be viewed on the Internet at: http://www.infinitink.com/consumer/.
During the program, Martin Schmieg, Chairman and CEO and Christine Solari, Senior Vice President of Research, Development & Manufacturing at Nuvilex, Inc., discuss Infinitink's design, development and use. Infinitink provides consumers with the ability to remove, change or redesign a tattoo more easily, with less cost, discomfort and time.
Martin Schmieg commented, "Infinitink is a new tattoo ink. It is as permanent as today's conventional inks, but 2-3 times more easily removed should the consumer change their mind. Surveys indicate that 25% of people over the age of 18 have tattoos and another 25% are "fence-sitters," -- people who are interested in getting a tattoo but don't act on it. By offering consumers a tattoo ink that does not require a lifetime commitment, we believe we can appeal to a much wider audience, and potentially even double the size of the tattoo market."
About Nuvilex, Inc.
Nuvilex is an emerging healthcare consumer products company with a portfolio of aesthetics, dermatology, environmental and nutraceutical products. The company's focus is on developin
|SOURCE Nuvilex, Inc.|
Copyright©2009 PR Newswire.
All rights reserved